Skip to main content

Animations

MJFF Publications

3821 - 3830 of 8404 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2020.627199
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: The Membrane Interactions of Synuclein: Physiology and Pathology
    Journal Name: Annual Review of Pathology: Mechanisms of Disease
    Publisher: Annual Reviews
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1146/annurev-pathol-031920-092547
    Citation Count: 35
  • Summary Details
    RESTRICTED
    Title: N-terminal acetylation does not alter α-synuclein's interfacial properties
    Journal Name: International Journal of Biological Macromolecules
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ijbiomac.2021.01.147
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Author Correction: The effect of LRRK2 loss-of-function variants in humans
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-020-01185-6
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465
    Best OA location URL:
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
    Journal Name: Journal of Neuroscience Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jnr.24782
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202013257
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Deubiquitinating enzyme amino acid profiling reveals a class of ubiquitin esterases
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2006947118
    Citation Count: 74
  • Summary Details
    RESTRICTED
    Title: Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms22031045
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12254
    Citation Count: 37
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.